Introduction {#s1}
============

Substance dependence (or substance addiction) is a chronic relapsing brain disorder leading patients to use a substance continuously despite the negative consequences that result from doing it ([@B1]). Many types of substances can cause addiction, such as addictive drugs including alcohol and tobacco. According to statistics released by the United Nations Office of Drug and Crimes, the percentage of individuals using cannabis, cocaine, and opioid worldwide were 3.8, 0.37, and 1.08%, respectively, in 2017 ([@B2]). Meanwhile, the harmful use of alcohol was estimated to cause 2.5 million deaths each year ([@B3]) and tobacco use causes more than five million deaths worldwide each year ([@B4]).

In the meantime, food addiction can be described as the dependence on refined foods that meets the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) substance use disorder criteria ([@B5]). Food addiction is significantly linked to obesity ([@B6]). Considering around 93.3 million US adults ([@B7]) and about 86 million people in China ([@B8]) could be classified as obese in 2016, food addiction is similar to substance addiction because food regulates body process by acting as the source of required energy and has a hedonic component that makes it an effective natural reward. Food-related rewards may promote increased intake and trigger withdrawal-related symptoms (e.g., overeating), suggesting that the behaviors parallel substance abuse ([@B9]). One possible explanation for food addiction (or overeating) is that sugar, fats, salt, caffeine, refined sweeteners, and refined carbohydrates in processed foods are addictive substances ([@B5]).

With substance addiction or food addiction, craving is dependent upon the past experience of an urge or desire to use substances ([@B10]). Reducing craving is an important aspect of treating substance dependence or food addiction. A direct method to reduce craving is pharmacotherapy ([@B11]--[@B14]), which is a long-term therapy focused on substitution or withdrawal. Because the use of medication carries a risk of damaging cardiopulmonary function ([@B15]), its application requires care. Cognitive treatments such as cognitive-behavior coping skills treatment (CBT) ([@B16]) and psychological counseling ([@B17]) are other mainstream treatments for helping patients recognize, avoid, and cope with the substance. It is often used with medications that interact with the type of psychotherapy provided ([@B18], [@B19]). Additionally, with the development of neural science, non-invasive neurostimulation techniques, including transcranial direct current stimulation (tDCS) and transcranial magnetic stimulation (TMS), have been widely used to reduce substance cravings ([@B20], [@B21]). Electromagnetic brain stimulation could regulate activity in specific brain regions. Recent studies have explored the application of non-invasive neurostimulation for the treatment of substance dependence ([@B22]--[@B25]).

Among them, tDCS, which uses a weak safe current of 1--2 mA for 3--20 min to increase (anodal tDCS) or decrease (cathodal tDCS) cortical excitability ([@B26], [@B27]), has a significant effect on reducing cravings ([@B28], [@B29]). However, the results of the effect of tDCS on drug craving are mixed. Salling et al. ([@B30]) reviewed research on brain stimulation in addiction and found that tDCS has an acute effect on drug and alcohol cravings without consistent results. Coles et al. ([@B31]) found that tDCS reduced craving and consumption for alcohol and drugs while the results for tobacco were unclear because of different stimulation methods and parameters. Some studies indicated that a single stimulation of the left dorsolateral prefrontal cortex (DLPFC) with anodal tDCS significantly reduced cravings ([@B32]--[@B35]), but other findings did not support this conclusion ([@B36]--[@B38]). This kind of inconsistency may come from different study designs, stimulation parameters, and characteristics of participants in different studies.

Considering the inconsistent findings of empirical investigations and that only a medium effect of tDCS was found in a meta-analysis, it is essential to explore potential modulators separately. In 2013, Jansen et al. ([@B39]) performed the first meta-analysis in this field (both TMS and tDCS studies included). After comparing the effects on alcohol/nicotine users and people with a high craving for food, the results indicated that craving levels were decreased in substance dependence following non-invasive neurostimulation of the prefrontal cortex and further revealed a significant medium effect size of neurostimulation, but no difference between substances, stimulation technology, or side of stimulation. Recently, another meta-analysis from Song et al. ([@B40]) reported a medium effect size of TMS and tDCS treatment on craving and consumption, making a comparison between substance type/stimulation sessions/stimulated regions and found that multi-session stimulation had larger effects. Different from existing research, this meta-analysis evaluates tDCS based on separate stimulation parameters (e.g., the stimulation site, current intensity, number of sessions, duration of single-stimulation, and total-stimulation); the duration of stimulation, in particular, has seen little prior analysis. Substance type and study design may be important modulators that need to be investigated in depth. We aimed to conduct a meta-analysis focusing on the effects of tDCS in decreasing substance/food craving, and exploring the influence of potential modulators systematically. This should help find the optimal stimulation parameters in clinical settings for drug dependence and food addiction.

Methods {#s2}
=======

An online search was conducted in the Web of Science, PubMed, and Google Scholar databases for articles published from January 2008 to January 2020. This search was implemented following the PICO-method (Patient/Population, Intervention, Comparison, Outcome) building a framework where "substance or food addiction" represented "P," "tDCS stimulation" represented "I," "active and sham stimulation" represented "C," and "craving" represented "O". The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines were followed in this meta-analysis.

Inclusion and Exclusion Criteria for the Selection of Studies {#s2_1}
-------------------------------------------------------------

We searched for the combination of two sets of pre-defined terms in the title or abstracts. The following terms were set as the search terms: (transcranial direct current stimulation OR tDCS) AND (substance dependence OR substance abuse OR alcohol OR drug OR tobacco OR nicotine OR eating disorder OR food addiction).

All studies included in the meta-analysis met the following inclusion criteria: 1) tDCS was used as the stimulation tool; 2) substance craving/food craving changes were measured; 3) sham stimulation as a control condition; and 4) means, standard deviations, t, F, or p statistics and the number of participants in each intervention group were provided completely as basic data in order to calculate effect size.

Studies were excluded if: 1) they were meta-analyses, reviews, meeting abstracts, or case studies; 2) the subjects had other mental disorders other than substance addiction/food addiction; 3) tDCS was used combined with other intervention strategies (e.g., cognitive training or psychotherapy); or 4) the subjects were animals.

Data Extraction {#s2_2}
---------------

### Stimulation Parameters {#s2_2_1}

The most important stimulation parameters were stimulation site (left DLPFC, right DLPFC, or other area), current intensity (2 mA or 1 mA), number of stimulation sessions (single-session or multi-session), duration of single-stimulation (10--30 min), and total-stimulation (10--200 min).

### Substance Type {#s2_2_2}

Four types of substance dependence were analyzed: drugs (e.g., cocaine, marijuana, methamphetamine, heroin, and opium), tobacco, alcohol, and food.

### Study Design {#s2_2_3}

Studies included in this meta-analysis were divided into double-blind or single-blind experiments, and into parallel experiments (i.e., more than two groups of participants and each group receives different treatments) and crossover experiments (all participants receive the same treatments but in a random order).

### Craving Measures {#s2_2_4}

The main outcome measures included in this meta-analysis were state craving scores from different questionnaires. For each study, craving scores pre-tDCS and post-tDCS of all participants (both active and sham groups) were obtained. Effect sizes on craving levels were standardized for the effect of stimulation.

Data Analysis {#s2_3}
-------------

The Cochrane Collaboration\'s risk of bias tool was used to judge the risk of bias within individual studies ([@B41]). The publications identified through this search strategy were then examined by the three researchers (JQ, JC, and ZZ) individually to confirm eligibility. If there was any disagreement, it was resolved by discussion.

### General Meta-Analysis {#s2_3_1}

The Comprehensive Meta-Analysis 2.0 (CMA 2.0) computer program was used to process and analyze the data. Main analyses were implemented to examine the effects of tDCS on craving. To measure the difference in craving levels between active and sham stimulation, effect sizes (Hedges\' *g*) were calculated. According to Borenstein et al. ([@B42]), Hedges\' *g* is regarded as a conservative estimate, which could be applied to studies regardless of sample sizes. Basing on the value of *g,* the results may be defined as reflecting a small (g=0.2--0.5), medium (g=0.5--0.8), or large (g\>0.8) effect.

### Moderator Analyses {#s2_3_2}

A random-effects model was used to analyze the difference between subgroups. Compared with the fixed effects model, the random effects model interval provides an unadventurous estimate of accuracy allowing for the existence of heterogeneity, which is more suitable for generalization ([@B42]). All comparisons used an alpha of 0.05.

The meta-regression was used to identify whether the duration of stimulation might influence the effect size estimates. Since every study was weighted by the precision of their respective effect estimates, the influence on the relationship depended on the size of study. This allows for residual heterogeneity among intervention effects rather than being modeled by explanatory variables ([@B43]).

### Publication Bias {#s2_3_3}

Publication bias analyzes whether the decision to publish or distribute a study was influenced by its findings ([@B44]). Publication bias was assessed using Egger\'s regression test ([@B45]). If publication bias was identified, a trim-and-fill procedure was applied to modify the effect size caused by publication bias ([@B46]).

Results {#s3}
=======

Studies Included in the Meta-Analysis {#s3_1}
-------------------------------------

The literature search identified 32 eligible studies (see [**Table 1**](#T1){ref-type="table"}). [**Figure 1**](#f1){ref-type="fig"} shows the flow diagram of the inclusion and exclusion process. Of the included studies, 8 for nicotine, 10 for alcohol, 7 for food, and 7 for other drug cravings. There were four studies in which subjects received two types of active anodal stimulation at different sites in independent sessions ([@B33], [@B34], [@B57], [@B68]). The four studies were divided into eight "units of analysis." We adjusted for the interdependence of these data in the analyses by taking *study* as a unit of design instead of the *unit for analyses* because in this case it was difficult to distinguish differences in both design and stimulation locations ([@B39]). Therefore, there were 36 units of analysis included in total. The assessment of the risk of bias for all studies included is summarized in [**Supplementary Table 1**](#SM1){ref-type="supplementary-material"}.

###### 

Studies included in the meta-analysis.

  Author                              Stimulation parameters   Study design   Participant\'s characteristics                                           
  ----------------------------------- ------------------------ -------------- -------------------------------- -------- ---- -------- ----------- ---- -------
  Fregni et al. ([@B34])              A-R/L DLPFC              2 mA           1                                20 min   CO   Double   Nicotine    24   VAS
  Boggio et al. ([@B47])              A-L DLPFC                2 mA           5                                20 min   PR   Double   Nicotine    27   VAS
  Fecteau et al.([@B48])              A-R DLPFC                2 mA           5                                30 min   CO   Double   Nicotine    12   sQSU
  Kroczek et al. ([@B36])             A-L DLPFC                2 mA           1                                15 min   PR   Double   Nicotine    25   VAS
  Yang et al. ([@B49])                A-L DLPFC DLPFC          1 mA           1                                30 min   CO   Single   Nicotine    32   VAS
  Xu et al. ([@B38])                  A-L DLPFC                2 mA           1                                20 min   CO   Single   Nicotine    24   UTS
  Mondino et al. ([@B50])             A-R DLPFC                2 mA           10                               20 min   PR   Double   Nicotine    29   LTS
  Hajloo et al. ([@B51])              A-L DLPFC                2 mA           10                               20 min   PR   Double   Nicotine    40   DDQ
  Boggio et al. ([@B33])              A-R/L DLPFC              2 mA           1                                20 min   CO   Double   Alcohol     13   AUQ
  Silva et al. ([@B52])               A-L DLPFC                2 mA           5                                20 min   PR   Single   Alcohol     13   OCDS
  Klauss et al. ([@B53])              A-R DLPFC                2 mA           5                                26 min   PR   Single   Alcohol     33   OCDS
  den Uyl et al. ([@B54])             A-L DLPFC                1 mA           1                                10 min   PR   Single   Alcohol     41   AAAQ
  Wietschorke et al. ([@B55])         A-R DLPFC                1 mA           1                                20 min   PR   Double   Alcohol     30   VAS
  Klauss et al. ([@B56])              A-R DLPFC                2 mA           10                               20 min   PR   Double   Alcohol     49   OCDS
  Nakamura-Palacios et al. ([@B37])   A-L DLPFC                1 mA           1                                10 min   CO   Single   Alcohol     49   OCDS
  Fregni et al. ([@B57])              A-R/L DLPFC              2 mA           1                                20 min   CO   Double   Food        21   VAS
  Goldman et al. ([@B58])             A-R DLPFC                2 mA           1                                20 min   CO   Single   Food        19   VAS
  Kekic et al. ([@B59])               A-R DLPFC                2 mA           1                                20 min   CO   Double   Food        17   FCQ-S
  Lapenta et al. ([@B60])             A-R DLPFC                2 mA           1                                20 min   CO   Double   Food        9    VAS
  Jauch-Chara et al. ([@B61])         A-R DLPFC                1 mA           8                                20 min   CO   Single   Food        14   VAS
  Georgii et al. ([@B62])             A-R DLPFC                1 mA           1                                20 min   CO   Double   Food        42   FCQ-S
  Montenegro et al. ([@B63])          A-L DLPFC                2 mA           1                                20 min   CO   Single   Food        9    VAS
  Ray et al. ([@B64])                 A-R DLPFC                2 mA           1                                20 min   CO   Double   Food        18   VAS
  Ray et al. ([@B65])                 A-R DLPFC                2 mA           1                                20 min   PR   Single   Food        74   FCT
  Chen et al. ([@B66])                A-R IFG                  1.5 mA         1                                20 min   PR   Single   Food        57   FCQ-S
  Batista et al. ([@B67])             A-R DLPFC                2 mA           5                                20 min   PR   Double   Cocaine     36   OCCS
  Boggio et al. ([@B68])              A-R/L DLPFC              2 mA           1                                15 min   PR   Double   Marijuana   25   VAS
  Shahbabaie et al. ([@B69])          A-R DLPFC                2 mA           1                                20 min   CO   Double   Meth        30   VAS
  Wang et al. ([@B70])                A-OL                     1.5 mA         1                                20 min   PR   Single   Heroin      20   VAS
  Shahbabaie et al. ([@B71])          A-R DLPFC                2 mA           1                                26 min   CO   Double   Meth        15   VAS
  Taremian et al. ([@B72])            A-R DLPFC                2 mA           10                               20 min   PR   Single   Opium       60   DDQ
  Anaraki et al. ([@B73])             A-R DLPFC                2 mA           5                                20 min   PR   Single   Meth        30   DDQ

A-R, anodal-right; A-L, anodal-left; DLPFC, dorsolateral prefrontal cortex; OL, occipital lobe; IFG, inferior frontal gyrus; CO, crossover; PR, parallel; Meth, methamphetamine; VAS, Visual Analogue Scale; sQSU, standardized Questionnaire of Smoking Urges; OCCS, Obsessive-Compulsive Cocaine Scale; LTS, Likert-type scale; UTS, urge to smoke; DDQ, The Desire for Drug Questionnaire; AUQ, Alcohol Urge Questionnaire; OCDS, Obsessive Compulsive Drinking Scale; AAAQ, Alcohol Approach and Avoidance Questionnaire; FCQ-S, Food Craving Questionnaire State; FCT, Food Craving Task.

![Flow diagram showing the search and selection procedure that was used for this meta-analysis. It showed the reasons for exclusion in "not meeting criteria" and final numbers of study included in the meta-analysis.](fpsyt-11-00598-g001){#f1}

General Effect Size (Hedges\' *g*) on Craving {#s3_2}
---------------------------------------------

The test for heterogeneity was significant (Q=55.44, df=31, *p*=0.004, I^2^=44.08%), showing that there was heterogeneity between the study findings. In order to address the heterogeneity problem, we used a random effects analysis for the meta-analysis because of its conservative estimate and appropriate nature for generalization ([@B42]). As shown in [**Figure 2**](#f2){ref-type="fig"}, this analysis revealed a standardized effect size (Hedges\' *g*) of 0.536 \[95% confidence interval (CI): 0.389--0.683\], indicating a medium effect size favoring active stimulation over sham stimulation (z=7.153, p\<0.001). The variation caused by the true difference in the effect accounts for 44.08% of the total variation with medium heterogeneity in this study, which implies that there may be important potential modulating variables and subgroup analysis was needed to test for the moderating effects ([@B74], [@B75]).

![The overall effect of transcranial direct current stimulation (tDCS) on craving.](fpsyt-11-00598-g002){#f2}

Influence of Moderators {#s3_3}
-----------------------

### Stimulation Parameters (Stimulation Site, Current Intensity, Number of Sessions) {#s3_3_1}

The left or right DLPFC was the anodal stimulation site in all studies except two ([@B66], [@B70]), which were excluded from this subgroup analysis, leaving 13 units for the left DLPFC and 21 units for the right DLPFC. Comparisons were made between the left and right DLPFC regardless of the cathodal site. The results showed that the difference between the left DLPFC and right DLPFC was not significant (Q=2.673, *p*=0.102) although Hedges\' *g* for the left DLPFC was 0.402, while the Hedges\' *g* for the right DLPFC was 0.636.

As far as current intensity was concerned, a comparison was made between 1 mA and 2 mA \[six studies with 1 mA, 24 studies with 2 mA, two studies was not included because the stimulation current was 1.5 mA ([@B66], [@B70])\]. There was no significant difference in effect size between 1 and 2 mA (Q=1.635, *p*=0.201); the Hedges\' *g* was 0.381 for 1 mA and 0.592 for 2 mA ([**Table 2**](#T2){ref-type="table"}).

###### 

Results of subgroup analysis (random-effects model).

  Moderators                  *k*   Hedges\' *g*   95% CI             Heterogeneity   
  --------------------------- ----- -------------- ------------------ --------------- -------
  **Stimulation site**                                                2.673           0.102
  Left DLPFC                  13    0.402\*\*\*    \[0.195, 0.609\]                   
  Right DLPFC                 21    0.613\*\*\*    \[0.446, 0.826\]                   
  **Current intensity**                                               1.478           0.224
  1 mA                        6     0.381\*\*\*    \[0.102, 0.661\]                   
  2 mA                        24    0.583\*\*\*    \[0.417, 0.748\]                   
  **Number of sessions**                                              4.261           0.039
  Single-session              21    0.444\*\*\*    \[0.272, 0.615\]                   
  Multi-session               11    0.751\*\*\*    \[0.515, 0.987\]                   
  **Substances type**                                                 4.121           0.249
  Nicotine                    8     0.555\*\*\*    \[0.309, 0.800\]                   
  Alcohol                     7     0.587\*\*\*    \[0.166, 1.008\]                   
  Food                        10    0.371\*\*\*    \[0.122, 0.620\]                   
  Drugs                       7     0.742\*\*\*    \[0.483, 1.000\]                   
  **Double or single**                                                0.405           0.524
  Double                      18    0.582\*\*\*    \[0.404, 0.761\]                   
  Single                      14    0.483\*\*\*    \[0.236, 0.730\]                   
  **Crossover or parallel**                                           0.913           0.339
  Crossover                   16    0.471\*\*\*    \[0.266, 0.677\]                   
  Parallel                    16    0.614\*\*\*    \[0.405, 0.823\]                   

\*\*\*p \< .01.

A comparison was also made between the number of sessions (single-session *vs*. multi-session) (21 studies with one session, and 11 studies with multiple sessions). The Hedges\' *g* for single-session stimulation was 0.443, while the Hedges\' *g* for multi-session stimulation was 0.751 (see [**Figure 3**](#f3){ref-type="fig"}). The results revealed a significant difference in effect size between the two subgroups (Q=4.261, *p*=0.039) (see [**Table 2**](#T2){ref-type="table"}). We found multiple session of tDCS intervention may have a better effect on craving.

![The difference between single session and multi-session.](fpsyt-11-00598-g003){#f3}

### Duration of Single Stimulation and All Stimulation {#s3_3_2}

We performed a meta-regression analysis based on the duration of single stimulation and Hedges\' *g*. Regarding the duration of single stimulation, we found a marginally significant result that the longer the stimulus lasts, the more the craving decreases (Q=2.832, *β*=0.023, *p*=0.092) (see [**Figure 4**](#f4){ref-type="fig"}). Due to only the presence of only five values and the marginally significant result, we extended the analysis to include total stimulation time (duration of single stimulation × number of sessions) to obtain a more credible result. Regarding total stimulation duration, we found that longer stimulation was related to greater effect size (Q=8.505, *β*=0.003, *p*=0.004) (see [**Figure 5**](#f5){ref-type="fig"}).

![Regression of the duration of single-stimulation on the effect size of neuromodulation of craving. (Q=2.832, *β*=0.023, *p*=0.092).](fpsyt-11-00598-g004){#f4}

![Regression of sessions on the effect size of neuromodulation of craving. (Q=8.505, *β*=0.003, *p*=0.004).](fpsyt-11-00598-g005){#f5}

### Substance Type {#s3_3_3}

We compared the results for alcohol users, nicotine users, drug users, and food bingers. The results did not show a significant difference in effect size between substance types \[Q (3)=4.121, *p*=0.249\] (see [**Table 2**](#T2){ref-type="table"}).

When substance type was divided into two categories, substance and food, where alcohol, nicotine, and drugs were combined into substance, the Hedges\' *g* for substance was 0.616, while the Hedges\' *g* for food was 0.371. However, there was no significant difference between substance and food (Q=2.474, *p*=0.116).We also compared food with other substance types separately, and found that there was an obvious difference between drugs and food (Q=4.094, *p*=0.043), but no difference between alcohol and food nor nicotine and food.

### Study Design (Crossover-Design or Parallel-Design; Double-Blind or Single-Blind) {#s3_3_4}

A comparison was made between study designs. No significant difference was found between crossover and parallel designs (Q=0.913, *p*=0.339) or between double and single blind designs (Q=0.405, *p*=0.524) (see [**Table 2**](#T2){ref-type="table"}). However, we found that the number of sessions may influence the results because most (8/11) multiple stimulation studies were parallel designs. Therefore, we compared the effects of the crossover design and parallel design by using the number of sessions as a covariate. The result confirmed no significant difference in effect size between crossover and parallel designs (Q=1.77, *p*=0.183).

Evaluation of Publication Bias {#s3_4}
------------------------------

Egger\'s regression test was performed to empirically examine the presence of any publication bias. A publication bias was observed (*p*=0.031), as shown in [**Figure 6**](#f6){ref-type="fig"}. A funnel plot was created ([@B76]) in which the measure of precision (standard error) of the effect size (Hedges\' *g*) was shown with a trim-and-fill procedure applied ([@B46]). The results of the trim and fill method highlighted that there are seven "missing" effect sizes on the left side of the funnel plot. After adjustment, the analysis indicated an average effect size of 0.416 (95% CI: 0.262--0.570), which was comparable to the original result (Hedges\' *g*=0.536), suggesting that the publication bias influenced our results lightly.

![Funnel plot for a model without moderators (random-effects model), the solid circles in the funnel plot represents the seven studies that were trimmed to the left. The solid diamond on the abscissa indicate that the correction effect size is 0.416, and the hollow diamond on the right represents the original effect size is 0.536.](fpsyt-11-00598-g006){#f6}

Discussion {#s4}
==========

Based on 32 empirical studies, we performed a meta-analysis to review the effect of tDCS on substance craving and the influence of potential moderators. The results revealed a significant medium effect size (Hedges\' *g*=0.536 or 0.416 after adjusting for publication bias) favoring real tDCS stimulation over sham stimulation in the reduction of craving. Furthermore, the number of sessions could significantly influence the effect of tDCS, favoring multi-session over single-session treatment. Other modulators appear to have no influence on craving reduction, such as stimulation site, current intensity, substances type, or study design.

Effect of Transcranial Direct Current Stimulation on Reducing Craving and Its Possible Mechanism {#s4_1}
------------------------------------------------------------------------------------------------

Our findings confirmed that there was significant decrease in craving after tDCS stimulation of the DLPFC, which supports previous findings ([@B39], [@B40], [@B77], [@B78]).

One possible mechanism by which DLPFC stimulation decreases craving is an increase in "cognitive control." As we know, the executive control network (ECN, including the DLPFC, orbitofrontal cortex, and anterior cingulate cortex) plays an important role in human executive control ([@B79]--[@B81]), including craving control ([@B82], [@B83]). tDCS can induce and regulate neural plasticity ([@B84]). Bilateral tDCS with anodal stimulation of the right DLPFC increases the intra-network functional connectivity ([@B71]). Cavaliere et al. ([@B85]) also showed that anodal tDCS over the DLPFC increases intra-network co-activation of the ECN. Thus, increased ECN activity and functional connectivity of the ECN could help individuals to decline or reduce craving---in other words, after changing the activity of the DLPFC subjects were able to better suppress their urges through its connections to the ECN.

Stimulation of the prefrontal cortex-stimulated dopaminergic pathways is another explanation. Addicted subjects were hardly roused by nondrug-related stimuli other than the substance they were addicted to, with decreased dopamine function disrupting frontal inhibition ([@B86]). Researchers have found that DLPFC stimulation alters the activation and functional connectivity of the cortical and subcortical reward systems in healthy individuals ([@B87]). Simultaneously, the membrane potential of pyramidal cells are regulated by anodal and cathodal tDCS, which alter the glutamate tone in the cortex, which is considered to correlate with GABA release, to restore the best excitation/inhibition balance to achieve the best steady-state plasticity in learning and cognition ([@B88]). Thus, tDCS stimulation of the DLPFC may improve the behavior of substance-dependent individuals by modulating the activities of brain regions such as the anterior cingulate cortex (ACC), the orbitofrontal cortex (OFC), and caudate nucleus.

However, it is not clear how tDCS affects substance and food craving. Further studies are needed to explore the psychological process and neural mechanisms underlying tDCS stimulation at the same time. A promising method can be seen in studies that use functional magnetic resonance imaging (fMRI) to explore the changes caused by tDCS stimulation ([@B87], [@B89]).

Influence of Moderators {#s4_2}
-----------------------

Among all the stimulation parameters, our subgroup analyses showed that multi-session tDCS had a significant greater effect on reducing craving than single-session tDCS, which is in agreement with Song et al.\'s ([@B40]) and Kim et al.\'s ([@B77]) findings. This suggests that the effects of tDCS on craving reduction can be cumulative. However, it is worth noting that the multiple stimulations included in the meta-analysis were all performed separately and not on the same day, because one study reported there was no benefit of twice-daily stimulation over once-daily stimulation in increasing cortical excitability ([@B90]).

Although not significant, we found a trending positive influence of the duration of single stimulations (*p*=0.092). The non-significant results may be because there were sufficient data in the analysis. After calculating the total stimulation duration, there was a trend that longer durations were related to larger Hedges\' *g* (*p*=0.004). The result is consistent with the finding that the duration of stimulation may enhance its efficacy in given applications ([@B91]). However, more evidence of the effect of stimulation duration is needed in future.

According to the substance type subgroup analyses, the effects on drug users were the biggest (Hedges\' *g*=0.742), followed by alcohol and nicotine (Hedges\' *g*=0.587 and Hedges\' *g*=0.555), and then food (Hedges\' *g*=0.371), suggesting that the process of food addiction may differ from substance addiction. In some study, food addiction has a bearing on stress exposure with damage to the hippocampus ([@B92]) and patients with food addiction were easily affected by a sad mood ([@B93]). Stress, cognition, and emotion recognition may play a more important role in food addiction than other addictions meaning the treatment of food addiction may be more complex.

As for other factors, since the beneficial effects of tDCS vary with the pathology ([@B94]), we speculate that tDCS may be more effective for severely addictive substances than lightly addictive substances. That is to say that the severity of addiction may be a factor influencing the effect size of tDCS. However, the severity of addiction cannot be determined in the current study because there is no consistent standard for severity across various addictions and we have difficulty extracting effective data to distinguish the severity of addiction in the current literature.

Although we tried to explore various regulatory variables, there are still some possible influencing variables, which are not discussed in this paper, such as tDCS combined with other treatments (cognitive bias modification, emotional regulation). tDCS combined with cognitive bias modiﬁcation has shown limited effect on treatment outcomes ([@B95]--[@B97]). Moreover, emotional regulation can help the curative effects of tDCS ([@B98]--[@B101]); after emotion regulation training, using tDCS has better results ([@B100]). Thus, different substance addictions may affect the participants\' emotional management, in turn altering the effects of tDCS. Due to the limited number of studies and the great heterogeneity among the literature, they were not included in the current meta-analysis. However, these works are of great significance and may be a new trend for tDCS research that deserves further research.

Regarding stimulation site, we found that there was no difference between right/anodal, left/cathodal and left/anodal, right/cathodal protocols for substance, and food dependence, supporting the conclusion of Jansen et al. ([@B39]) that putting the anode on the left or right would not affect the results of treating addictive disorders. However, although not significant, we could not ignore that the right DLPFC may be a better choice for most individuals because of the higher Hedges\' *g* (0.613) than that of the left DLPFC (0.402). Boggio et al. ([@B68]) showed that only the right anode + left cathode montage was significantly associated with a reduction of craving for marijuana. It seems there may have the possibility that the effect of stimulation site will depend on the health status of the subject and the type of substance dependence. Other parameters, including current intensity (1 *vs*. 2 mA), study design (crossover or parallel, and double blind or single blind) had no significant difference.

Limitations and Future Directions {#s4_3}
---------------------------------

In this meta-analysis, some limitations should be considered. First, the number of libraries and articles available was limited. Although we searched for accessible published articles, we still could not be sure that all relevant research was included. Second, the main effect of tDCS is only a medium effect size, suggesting more empirical studies are needed to explore the modulators of tDCS treatment of craving control, e.g., the substance type, addiction severity, and abstinence duration. Unfortunately, the majority of included studies did not report the abstinence duration or addiction severity; therefore, we could not examine its moderating effect in tDCS performed for craving control. Thus, an in-detail report of dependence-related data would be very important in the future. Third, the tools for measuring cravings need to be improved. In most studies, craving was measured using self-report questionnaires or visual analogue scales, which are subject to socially desirable answers. Some objective methods to measure drug craving (e.g., physiological measurement) would be very helpful in investigating the effect size of craving reduction.

Conclusion {#s5}
==========

The current meta-analysis provided evidence that tDCS protocols improved the symptoms of substance and food dependence as indicated by reduced craving, but some modulators does influence the effect of tDCS treatment on addiction. In general, our findings suggested that 2 mA stimulation may be better than 1 mA; multi-session interventions may be better than single-session. We also suggested that tDCS may be not ideal for the treatment of food addiction, implicating that compared with substance addiction, food addiction may be different in nature and needs complex treatment such as tDCS combined with psychological interventions. In clinic, the optimal treatment plan for any specific type of addiction still needs be to be examined in depth in future.
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